These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 426691)

  • 1. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis.
    Stern GA; Okumoto M; Smolin G
    Arch Ophthalmol; 1979 Apr; 97(4):721-2. PubMed ID: 426691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
    Pleyer U; Legmann A; Mondino BJ; Lee DA
    Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of Candida endophthalmitis with a synergistic combination of amphotericin B and rifampin.
    Lou P; Kazdan J; Bannatyne RM; Cheung R
    Am J Ophthalmol; 1977 Jan; 83(1):12-5. PubMed ID: 319671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin.
    Ernst JD; Rusnak M; Sande MA
    Rev Infect Dis; 1983; 5 Suppl 3():S626-30. PubMed ID: 6356285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of corticosteroids in antimycotic therapy of Candida keratitis].
    Behrens-Baumann W; Küster M
    Klin Monbl Augenheilkd; 1987 Sep; 191(3):222-5. PubMed ID: 3682686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous effect of subconjunctival miconazole on Candida albicans keratitis in rabbits.
    O'Day DM; Head WS; Robinson RD; Williams TE; Gedde SJ
    Am J Ophthalmol; 1991 Nov; 112(5):562-6. PubMed ID: 1951595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of rifampin with other antifungal agents in experimental murine candidiasis.
    Graybill JR; Ahrens J
    Rev Infect Dis; 1983; 5 Suppl 3():S620-5. PubMed ID: 6356284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
    Behrens-Baumann W; Uter W; Ansorg R
    Klin Monbl Augenheilkd; 1987 Aug; 191(2):125-8. PubMed ID: 3669506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic action of amphotericin B and rifampin against Candida species.
    Beggs WH; Sarosi GA; Walker MI
    J Infect Dis; 1976 Feb; 133(2):206-9. PubMed ID: 1245767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):874-80. PubMed ID: 3553060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic action of amphotericin B and rifampin on Candida albicans.
    Beggs WH; Sarosi GA; Andrews FA
    Am Rev Respir Dis; 1974 Nov; 110(5):671-3. PubMed ID: 4611292
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of yeast growth phase in vivo on the efficacy of topical polyenes.
    O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
    Curr Eye Res; 1987 Feb; 6(2):363-8. PubMed ID: 3552454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
    Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
    Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1984; 22(4):323-30. PubMed ID: 6095470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports.
    Kanavi MR; Foroutan AR; Kamel MR; Afsar N; Javadi MA
    Cornea; 2007 Sep; 26(8):913-6. PubMed ID: 17721287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycotic keratitis.
    Med J Aust; 1970 May; 1(21):1026. PubMed ID: 5310739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.